Patent US3215078A successfully refreshed from Google Patents.
Patent US4515162A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3663374A Expired / Lapsed US ⏱️ 0.0 years remaining

Method and apparatus for quantitating enzyme activity

Assignee: Geomet Inc
•
Filing: 1970-08-14
•
Granted: 1972-05-16
•
Expires: 1990-08-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Method and apparatus for quantitating enzyme activity in blood and other fluids, using a spot test technique. The test utilizes enzyme standards freeze-dried in absorbent discs held under a membrane filter. Other discs above the filter contain substrate, cofactors, and indicators. The spot test plates are entirely self-contained, requiring neither instrumentation nor measurement of fluid volumes, and the test can be carried out under any ambient conditions. The test is particularly applicable to emergency screening requirements, such as may occur in hospital receiving rooms, doctors'' offices, ambulances, or whereever rapid diagnosis of myocardial infraction may be required.

Inventors

  • 👤 Rudolph H Moyer
  • 👤 Donald J Sibbett

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 20:56
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/48; C12Q1/50; C12Q1/26; C12Q1/32

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 25 words
In a system as claimed in claim 1, superposed slides mounting said stacked discs therebetween, said slides being sealed together and constituting prefabricated test packages.
Claim 2
Dependent Claim 44 words
In a system as claimed in claim 2, said discs severally having selected mutually incompatible in storage reagents required for a given test impregnated on separate said discs, said reagents contained in said discs being freeze-dried for separation and storage prior to test use.
Claim 3
Dependent Claim 56 words
In a system as claimed in claim 3, said upper glass fiber disc containing Cysteine hydrochloride, said lower glass fiber disc containing a composite of reagents required for a Creatine phosphokinase assay excluding N-methylphenazonium methosulfate and enzymes, said membrane filter disc containing N-methylphenazonium methosulfate, and said cellulose acetate disc containing Creatine phosphokinase, Hexokinase and Glucose-6-phosphate dehydrogenase.
Claim 4
Dependent Claim 73 words
In a system as claimed in claim 4, said composite of reagents comprising in concentration (mg./ml.): Reagents Concentration (mg./ml.) Cystein hydrochloride 1.0 Adenosine diphosphate 1.0 Nicotinamide adenine dinucleotide phosphate 1.0 Glucose 3.0 Adenosine-5''-monophosphate 4.0 Nitro blue tetrazoleum 1.0 Creatine phosphate 5.0 Magnesium acetate 2.0 N-Methylphenazonium methosulfate 0.1 Hexokinase 0.1 IU Glucose-6-phosphate dehydrogenase 5.0 IU Creatine phosphokinase 5.0 IU; and said reagents excluding Cysteine hydrochloride, being dissolved in glycylglycine buffer, adjusted to pH 6.8.
Claim 5
Dependent Claim 62 words
In a system as claimed in claim 5, a blood test specimen placed on said upper glass fiber disc in a reagent containing array taking up cysteine hydrochloride, reagents from said lower glass fiber disc, and N-methylphenazonium methosulfate from said membrane filter disc, delivering both filtered plasma and reagents to the enzymes on said cellulose fiber disc where the reaction takes place.
Claim 6
Dependent Claim 68 words
In a system as claimed in claim 5, each said area including a said stacked array, each said area comprising a spot, three said spots containing CPK standards representing normal, elevated, and high enzyme levels, respectively, a fourth said spot being a blank containing all reagents except creatine phosphate and the fifth said spot being adapted for assay of CPK and containing reagents for a complete reaction sequence.
Claim 7
Dependent Claim 85 words
In a method for quantitating enzyme activity in a system as claimed in claim 7, applying a drop of water to the upper sides of said three standards containing spots, applying a drop of whole blood to the upper sides of said fourth and fifth spots, inverting the slides mounting said stacked arrays constituting said spots, observing development of color and comparing intensity of color developed in said fifth spot with that in said three standards containing spots for a direct reading of CPK activity.
Claim 8
Dependent Claim 166 words
An enzyme CPK assay test unit for visual determination of enzyme content of whole blood comprising: A. a support; B. means constituting a plurality of test spots mounted on said support: i. at least first ones of said spots containing reagents for assay of CPK activity in blood serum including standards representing normal, elevated, and high enzyme levels; ii. an additional said spot being a blank containing all reagents in the first said spots except creatine phosphate; and iii. a further said spot containing reagents activatable by whole blood for a complete reaction sequence; iv. said reagents being mutually incompatible in storage and separated by impregnation on a plurality of discrete separate laminae which collectively constitute each said spot; v. said laminae in each said spot being in a rigidly confined stacked array and some said laminae constituting prefilters to remove amorphous matter including white cells from blood to prevent such matter from subsequently clogging pores of others of said laminae in a said stacked array.
Claim 9
Dependent Claim 76 words
A test unit as claimed in claim 9, said reagents being severally applied to discs constituting said laminae forming said spots to separate reagents incompatible in storage and being in a freeze-dried storage condition, the reagents in the first said spots being activated by water, activation of reagents in all said spots presenting an indicating color therein whereby enzyme content in whole blood is visually determinable by color comparison with the colors of the standard indicators.

References Cited (Backward Citations)

US3261668A Cited
US3367841A Cited
US3526480A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1975-05-16 1975-11-15 1976-05-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1979-05-16 1979-11-15 1980-05-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1983-05-16 1983-11-15 1984-05-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag